For a short period, it may seem fine, but the manufacturers set these instructions to ensure the medication stays effective and safe throughout its use
*Compounded versions of semaglutide are not FDA-approved, and neither the FDA nor any global regulatory agency has reviewed these products for safety, quality, or efficacy
The starting dose of semaglutide is 0.25 mg once a week (subcutaneously) for the first 4 weeks
Many providers recommend avoiding overeating, high-sugar foods, excessive alcohol, and extremely greasy meals, especially during the adjustment period
This treatment works as a dual agonist, targeting the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors in the body